Edwards Lifesciences Corp. (EW)
89.07
-1.02
(-1.13%)
USD |
NYSE |
Oct 23, 16:00
89.08
+0.01
(+0.01%)
After-Hours: 20:00
Edwards Lifesciences Enterprise Value : 47.91B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 47.91B |
| October 22, 2026 | 48.50B |
| October 21, 2026 | 47.53B |
| October 20, 2026 | 47.46B |
| October 19, 2026 | 46.85B |
| October 16, 2026 | 46.49B |
| October 15, 2026 | 47.35B |
| October 14, 2026 | 46.40B |
| October 13, 2026 | 45.72B |
| October 12, 2026 | 46.37B |
| October 09, 2026 | 45.69B |
| October 08, 2026 | 45.13B |
| October 07, 2026 | 46.02B |
| October 06, 2026 | 46.42B |
| October 05, 2026 | 46.85B |
| October 02, 2026 | 45.65B |
| October 01, 2026 | 45.68B |
| September 30, 2026 | 46.33B |
| September 29, 2026 | 47.34B |
| September 28, 2026 | 46.62B |
| September 25, 2026 | 46.31B |
| September 24, 2026 | 45.99B |
| September 23, 2026 | 46.62B |
| September 22, 2026 | 47.75B |
| September 21, 2026 | 47.49B |
| Date | Value |
|---|---|
| September 18, 2026 | 47.45B |
| September 17, 2026 | 47.44B |
| September 16, 2026 | 48.04B |
| September 15, 2026 | 45.99B |
| September 14, 2026 | 45.87B |
| September 11, 2026 | 45.20B |
| September 10, 2026 | 46.59B |
| September 09, 2026 | 46.25B |
| September 08, 2026 | 46.56B |
| September 04, 2026 | 48.39B |
| September 03, 2026 | 48.32B |
| September 02, 2026 | 48.92B |
| September 01, 2026 | 48.88B |
| August 31, 2026 | 48.88B |
| August 28, 2026 | 48.57B |
| August 27, 2026 | 48.42B |
| August 26, 2026 | 48.90B |
| August 25, 2026 | 48.95B |
| August 24, 2026 | 48.74B |
| August 21, 2026 | 48.33B |
| August 20, 2026 | 48.35B |
| August 19, 2026 | 49.76B |
| August 18, 2026 | 49.02B |
| August 17, 2026 | 48.92B |
| August 14, 2026 | 49.37B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intuitive Surgical, Inc. | 152.82B |
| Stryker Corp. | 129.78B |
| Abbott Laboratories | 207.10B |
| Zimmer Biomet Holdings, Inc. | 25.86B |
| Becton, Dickinson & Co. | 70.12B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 241.40M |
| Revenue (Quarterly) | 1.741B |
| Total Expenses (Quarterly) | 1.499B |
| EPS Diluted (Quarterly) | 0.4188 |
| Gross Profit Margin (Quarterly) | 78.09% |
| Profit Margin (Quarterly) | 13.87% |
| Earnings Yield | 1.89% |
| Operating Earnings Yield | 3.59% |
| Normalized Earnings Yield | 2.660 |